沃替西汀降低缓解期抑郁患者及健康对照者N-back工作记忆任务中的BOLD信号:一项随机神经影像试验
该随机双盲神经影像试验纳入缓解期抑郁患者(n=48)和健康志愿者(n=48),随机接受14天沃替西汀20 mg或安慰剂治疗,评估N-back工作记忆任务fMRI反应及神经心理表现。结果显示,与安慰剂相比,沃替西汀降低右侧背外侧前额叶皮层和左侧海马激活,并改善TMT-A表现和PDQ自评认知功能,效应见于两组受试者。
要点
- 沃替西汀降低右侧DLPFC和左侧海马N-back任务激活,方向与抑郁改变相反。
- 沃替西汀改善TMT-A表现和PDQ自评认知功能,效应见于抑郁患者和健康对照。
- 沃替西汀对认知神经环路的直接效应可与心境症状效应分离。
核心结论
- 沃替西汀在维持工作记忆表现的同时调节支持工作记忆的神经环路,方向与抑郁相关改变相反。
- 沃替西汀对支持认知功能的神经环路有直接效应,可与对抑郁心境症状的效应分离。
研究设计与样本
- 随机双盲神经影像试验,缓解期抑郁患者(n=48)和健康志愿者(n=48)随机接受14天沃替西汀20 mg或安慰剂。
- 基线和治疗结束时评估N-back工作记忆任务fMRI反应,并用TMT、Rey听觉学习测验、数字符号替换测验和PDQ评估认知。
主要发现
- 与安慰剂相比,沃替西汀降低N-back任务中右侧背外侧前额叶皮层和左侧海马激活。
- 沃替西汀提高TMT-A表现和PDQ自评认知功能。
- 上述效应在缓解期抑郁患者和健康志愿者两组中均可见。
临床怎么用
- 沃替西汀可能直接改善抑郁相关认知功能障碍的神经环路基础,而不仅通过改善心境起效。
- 临床评估认知症状时可关注TMT-A和PDQ等工具,但需结合个体情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cognitive dysfunction is common in depression during both acute episodes and remission. Vortioxetine is a novel multimodal antidepressant that has improved cognitive function including executive function in depressed patients in randomised placebo-controlled clinical trials. However, it is unclear whether vortioxetine is able to target directly the neural circuitry implicated in the cognitive deficits in depression. Remitted depressed (n=48) and healthy volunteers (n=48) were randomised to receive 14 days treatment with 20 mg vortioxetine or placebo in a double-blind design. The effects of treatment on functional magnetic resonance imaging responses during an N-back working memory task were assessed at baseline and at the end of treatment. Neuropsychological measures of executive function, speed and information processing, attention and learning and memory were examined with the Trail Making Test (TMT), Rey Auditory Learning Test and Digit Symbol Substitution Test before and after treatment; subjective cognitive function was assessed using the Perceived Deficits Questionnaire (PDQ). Compared with placebo, vortioxetine reduced activation in the right dorsolateral prefrontal cortex and left hippocampus during the N-back task compared with placebo. Vortioxetine also increased TMT-A performance and self-reported cognitive function on the PDQ. These effects were seen across both subject groups. Vortioxetine modulates neural responses across a circuit subserving working memory in a direction opposite to the changes described in depression, when performance is maintained. This study provides evidence that vortioxetine has direct effects on the neural circuitry supporting cognitive function that can be dissociated from its effects on the mood symptoms of depression.
引用
- Smith J, Browning M, Conen S, et al. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls. Mol Psychiatry. 2017. PMID: 28533517. doi:10.1038/mp.2017.104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。